Octofactor®

INN Moroctocog alfa

Recombinant activated coagulation factor VIII, which is required for the treatment of haemophilia A.

Octofactor was launched onto the Russian market in 2013.

GENERIUM is the only company in the world, which manufactures three recombinant coagulation factors (FVII, FVII and FIX) for the treatment of hemophilia A and B, including its inhibitor form.